Neoadjuvant Immunotherapy Shows Promise in Limited-Stage SCLC“Key Takeaways: Neoadjuvant chemoimmunotherapy in LS-SCLC shows high pCR and MPR rates, indicating promising efficacy before surgery. The meta-analysis found a 95% R0 surgical resection rate, with no...
Lung Cancer in Special Populations“Lung cancer is the leading cause of cancer deaths worldwide, claiming more lives than other age-related and screen-detectable cancers. Cigarette smoking remains the most important risk factor. However, despite common perceptions,...
Breakthrough lung cancer treatment supercharges immune cells with mitochondria “Scientists have found a way to supercharge lung cancer treatment by transplanting healthy mitochondria into tumors, which both boosts immune response and makes chemotherapy far more...
Radiation Therapy Overcomes Immunotherapy Resistance in Some Cancers“By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to the treatment, leading to positive outcomes for patients, according to new...
Multi-cohort analysis identifies a blood-based immune transcriptomic signature for early lung cancer detection“Early diagnosis of lung cancer is critical for timely intervention and reducing mortality. The immune system and cancer are intricately linked, which...
Ensuring Coverage of Faster Biomarker Testing in Lung Cancer: Robert Kratzke, MD“Delays in molecular testing for patients with non–small cell lung cancer (NSCLC) can lead to treatment lags that cost lives, warned Robert Kratzke, MD, professor of medicine and head of...
More News and Updates